Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on High time to tackle drug-resistant fungal infections.
fosmanogepix has proven anti-fungal activity in 4 of the 5 target classes and is in stage III trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11131969/
https://www.google.com/search?q=amplyx+pharmaceuticals
https://www.google.com/search?q=Fosmanogepix
There are no comments on this comment yet.
fosmanogepix has proven anti-fungal activity in 4 of the 5 target classes and is in stage III trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11131969/
https://www.google.com/search?q=amplyx+pharmaceuticals
https://www.google.com/search?q=Fosmanogepix